A groundbreaking study is bringing much-needed attention to the challenges faced by pregnant women with asthma in southern New South Wales. Asthma management during pregnancy is a critical yet often overlooked aspect of healthcare.
Queanbeyan Hospital has taken a significant step forward by becoming the first rural site to host the Treatable Traits in Pregnancy (TTAP) Study, funded by the National Health and Medical Research Council. This study aims to delve deeper into the unique experiences of pregnant women with asthma.
Midwife and research clinician Alexandra Overton, who leads the Queanbeyan branch, emphasizes the study's holistic approach. "We're taking a dynamic look at the whole picture," she explains. The study began with a pilot in 2024 and has since expanded to various sites across New South Wales and Victoria.
Queanbeyan's rural setting provides a unique perspective, according to Ms. Overton. "It adds a layer of depth to our research data and statistics, making it more comprehensive," she says. During the study, pregnant participants will attend three visits to discuss their "treatable traits"—factors that could worsen asthma symptoms.
"The focus is on understanding their symptoms, inhaler techniques, and providing personalized feedback," Ms. Overton explains. "We track their progress over these appointments to see if there are any improvements or deteriorations in asthma control."
The study also involves testing for inflammation and carbon monoxide levels, as well as checking lung capacity. Importantly, there are no changes to the participants' usual maternity care.
Initial data from the Queanbeyan site suggests a possible link between asthma and hyperemesis gravidarum, a condition characterized by severe nausea and vomiting during pregnancy. Ms. Overton notes, "There's an overlap in symptoms between asthma and other common pregnancy conditions like reflux and anxiety."
"Our goal is to tease out these correlations and understand them better over the course of the pregnancy," she adds.
The study provides "extra TLC" to participants over three appointments, offering a more personalized approach to asthma management during pregnancy. Ms. Overton highlights the importance of involving smaller communities in research and clinical trials.
"Many large studies focus on urban areas, but we risk missing important nuances in rural and regional communities if we don't include them," she says.
If you're interested in participating in this study, you can contact the research team by calling 0407 424 711 or emailing alexandramarie.reynolds @health.nsw.gov.au. This stage of the study concludes in March 2027.
But here's where it gets controversial... What are your thoughts on the potential impact of asthma management during pregnancy on the health of both mother and child? Do you think this study will lead to significant advancements in healthcare for pregnant women with asthma? We'd love to hear your opinions in the comments!
